5AM Ventures VI, L.P. → CAMP4 THERAPEUTICS CORPORATION CAMP

Stake: 9.90% Shares: 2,033,270 CUSIP: 13463J101 Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-08-14

DTC 5.22

1,276,571 shares short · -13.9% vs prior

Other 13D/G Filings on CAMP4 THERAPEUTICS CORPORATION

Filed	Form	Filer	Stake	Shares
2026-08-19	SCHEDULE 13D/A	Polaris Management Co. VII, L.L.C.	6.30%	3,023,161	view →
2026-08-05	SCHEDULE 13D/A	5AM Ventures VI, L.P.	9.90%	2,625,145	view →
2025-09-15	SCHEDULE	Enavate Sciences GP, LLC	8.10%	3,785,802	view →

Other Filings by 5AM Ventures VI, L.P.

Filed	Form	Issuer	Stake	Shares
2026-08-05	SCHEDULE 13D/A	CAMP4 THERAPEUTICS CORPORATION	9.90%	2,625,145	view →
2023-08-28	SC	Enliven Therapeutics, Inc. ELVN	—	—	view →
2023-02-28	SC	CinCor Pharma, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →